Skip Navigation


Zanetta S. Lamar, M.D.Wake Forest Baptist Health

Doctor Rating

4.8 out of 5

119 Ratings

Zanetta S. Lamar, M.D.

Assistant Professor,
Redox Biology & Medicine Ctr

Clinical Interests

Hodgkin and Non-Hodgkin Lymphomas

Contact Information

Returning Patient Appointments: 336-713-5440
Department: 336-716-4464

Insurance Accepted »

Education & Training

  • B.S., Grambling State University, 2003
  • M.D., Meharry Medical College, 2007
  • Residency, Internal Medicine, NC Baptist Hospital, 2010
  • Fellowship, Hematology And Oncology, WFU School of Medicine, 2013

Board Certifications

  • American Board of Internal Medicine, Internal Medicine

NPI Number

  • 1871776757
Zanetta S. Lamar, M.D.

Doctor Rating

4.8 out of 5

119 Ratings

Zanetta S. Lamar, M.D.

Assistant Professor, Hematology & Oncology
Redox Biology & Medicine Ctr

Research Interests

Lymphoma, Non-Hodgkin; Antineoplastic Combined Chemotherapy Protocols; Hemangiopericytoma; Meningioma; Antiretroviral Therapy, Highly Active
More »

Contact Information

Academic: 336-716-4464 | Department: 336-716-4464

Recent Publications

Endobronchial ultrasound transbronchial needle aspiration for the diagnosis of lymphoma. Gandotra S, Dotson T, Lamar Z, Bellinger C.. J Bronchology Interv Pulmonol. 2018;25(2):97-102.

Evaluating the response rates of VD-PACE in multiple myeloma [abstract]. Chen JE, Kennedy L, Lamar ZS, Rodriguez C.. Biol Blood Marrow Transplant. 2018;24(3 Suppl 1):S252.

A human bone marrow mesodermal-derived cell population with hemogenic potential. Mokhtari S, Colletti E, Yin W, Sanada C, Lamar Z, Simmons PJ, Walker S, Bishop C, Atala A, Zanjani ED, Porada CD, Almeida-Porada G.. Leukemia. 2018;():.

Evaluating interaction of cord blood hematopoietic stem/progenitor cells with functionally integrated three-dimensional microenvironments. Mokhtari S, Baptista PM, Vyas DA, Freeman CJ, Moran E, Brovold M, Llamazares GA, Lamar Z, Porada CD, Soker S, Almeida-Porada G.. Stem Cells Transl Med. 2018;7(3):271-282.

Frequency of left ventricular end-diastolic volume-mediated declines in ejection fraction in patients receiving potentially cardiotoxic cancer treatment. Melendez GC, Sukpraphrute B, D'Agostino RB Jr, Jordan JH, Klepin HD, Ellis L, Lamar Z, Vasu S, Lesser G, Burke GL, Weaver KE, Ntim WO, Hundley WG.. Am J Cardiol. 2017;119(10):1637-1642.

Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study. Lamar ZS, Dothard A, Kennedy L, Isom S, Robinson M, Vaidya R, Hurd D, McClain D, Lesser G.. Leuk Lymphoma. 2017;():.

Dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (EPOCH) with or without rituximab as first-line therapy for aggressive non-Hodgkin lymphoma. Lamar ZS, Fino N, Palmer J, Gruber L, Morris BB, Raetskaya-Solntseva O, Kennedy L, Vaidya R, Hurd D, Zamkoff K.. Clin Lymphoma Myeloma Leuk. 2016;16(2):76-81.

Timing of salvage therapy and autologous hematopoietic cell transplant in relapsed hodgkin and non hodgkin lymphoma [abstract]. Lamar ZS, Fino N, Hurd D, Howard D, McIver ZA, Phillips GL, Vaidya R.. Biol Blood Marrow Transplant. 2016;22(3 Suppl 1):S127-S128.

A phase II clinical trial of CPI-613 in patients with relapsed or refractory small cell lung carcinoma. Lycan TW, Pardee TS, Petty WJ, Bonomi M, Alistar A, Lamar ZS, Isom S, Chan MD, Miller AA, Ruiz J.. PLoS One. 2016;11(10):e0164244.

Endobronchial ultrasound transbronchial needle aspiration for the diagnosis of lymphoma [abstract]. Bellinger C, Parks G, Lamar Z, Dotson T.. Am J Respir Crit Care Med. 2016;193():A3390.

Single institution retrospective study of infusional etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin, (EPOCH) plus /- rituximab (R) as first line therapy for aggressive non-Hodgkin lymphoma [abstract]. Lamar ZS, Fitzgerald N, Palmer JM, Gruber L, RaetskayaSolntseva O, Kennedy L, Vaidya R, Zamkoff KW, Hurd DD.. J Clin Oncol. 2015;33(15 Suppl):e19514.

Ibrutinib and rituximab induced rapid response in refractory Richter syndrome. Lamar Z, Kennedy L, Kennedy B, Lynch M, Goad A, Hurd D, McIver Z.. Clin Case Rep. 2015;3(7):615-617.

A human bone marrow-derived stromal cell population with hemogenic potential [abstract]. Mokhtari S, Colletti EJ, Sanada C, Lamar ZS, Simmons PJ, Atala A, Krause DS, Zanjani ED, Porada CD, Almeida-Porada G.. Blood. 2015;126(23):1201.

Outcomes of second transplants for disease recurrence or for myelodysplasia (MDS) developing after an initial transplant (Tx) [abstract]. Naik S, D'Agostino R Jr, Lamar Z, Graham RM, Vatca M, Agnew E, Higgins A, Levitan D, Hurd D.. Biol Blood Marrow Transplant. 2012;18(2 Suppl 2):S340-S341.

Higher risk of severe drug-induced liver injury among Hispanic HIV-infected patients after initiation of highly active antiretroviral therapy. Lamar ZS, Nunez M.. J Int Assoc Physicians AIDS Care (Chic Ill). 2011;10(3):183-186.

Management of meningeal neoplasms: meningiomas and hemangiopericytomas. Lamar Z, Lesser GJ.. Curr Treat Options Oncol. 2011;12(3):230-239.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Assistant Professor, Hematology & Oncology

Clinical Interests

Hodgkin and Non-Hodgkin Lymphomas
Zanetta S. Lamar, M.D.

Zanetta S. Lamar, M.D.

Assistant Professor, Hematology & Oncology
Redox Biology & Medicine Ctr

Doctor Rating

4.8 out of 5

Zanetta S. Lamar, M.D.119 Ratings


Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
CP efforts to include in decisions
CP explanations of prob/condition
CP spoke using clear language
Friendliness/courtesy of CP
Likelihood of recommending CP
Patients' confidence in CP
Time CP spent with patient
Wait time at clinic

Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.


*Dr. Lamar explained everything very good to me. Like her as a person and doctor.


Dr. Lamar is a very caring physician who is easy to communicate with. She makes sure to inform you of the plan of care & asked for my questions. She has an easy going style and makes you feel comfortable. She got my labs while seeing her & discussed. I have complete confidence in her & think she is great!


No problems with Dr. Lamar


Dr Lamar is never in a hurry. She takes as much time as needed for my husband.very thorough to explain everything to us. Very caring!


9. Great!


Dr Lemar is WONDERFUL. !!!!!!


dr Lamar is fantastic but this survey is ridiculously long


Dr. Lamar always listens to my concerns and explains everything thoroughly


I have full confidence in Dr. Lamar!


Dr Lamar is the best. She has always been concerned with my care since I started seeing her in 2014 when I was diagnosed with cancer. She is amazing!


Excellent dr.!


I am a retired nurse. I retired 2 years ago and worked for 40 years in the profession with patient contact at all times. I worked very closely with physicians my last 9 years. Dr. Lamar is the best. She is knowledgeable, patient, understanding, kind and genuine. I could not have chosen a better oncologist for this journey. I have known Dr. Lamar for 2 years now, maybe a little longer. I would highly recommend her to any friend or family member. She has served her patients and community well.


very nice lady and seems to know what she is doing


*Dr. Lamar was great; easy to talk to; wrote everything down for me & gave notes to me. She looked at my list of questions to make sure she had answered everything. Feel very confident of her abilities and so happy & pleased she is my oncologist. She is compassionate & understanding.


Dr Lamar has been wonderful.....she has made this long and frightening road smooth and tolerable and I never thought that I was doing this alone.


Dr. Lamar is a very excellent physician. she explains things, very polite, answers all questions. being professional, a very nice person.


Dr. Lamar and her team are wonderful and I have every confidence they are doing the maximum they can for me. I trust them literally with my life and they do not let me down. I look forward to seeing them and I would never consider another team to help me.


Dr. Lamar's consultation was excellent and she provided new information about my cancer. She explained how they would proceed in clear, concise terms. All in all, this was a very good experience and I have great confidence in her ability to come up with the best treatment for my rare condition. She was outstanding in all respects.


*Dr. Lamar - Very thorough in explaining - Very good physician - Very caring of patients.


I have all the confidence in the world in *Dr. Lamar. She is the best ever and makes me feel comfortable.

Quick Reference

Request an Appointment
New Patients


Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Wake Forest Baptist Ranked among Nation’s ‘Best Hospitals’  25 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.